Kosma VM - Search Results

1

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.

Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC, Mahmoodi M, Schmidt MK, Broeks A, Cornelissen S, Braaf LM, Muir KR, Lophatananon A, Chaiwerawattana A, Wiangnon S, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, Sawyer EJ, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Guénel P, Truong T, Laurent-Puig P, Mulot C, Bojesen SE, Nielsen SF, Flyger H, Nordestgaard BG, Milne RL, Benítez J, Arias-Pérez JI, Zamora MP, Anton-Culver H, Ziogas A, Bernstein L, Dur CC, Brenner H, Müller H, Arndt V, Langheinz A, Meindl A, Golatta M, Bartram CR, Schmutzler RK, Brauch H, Justenhoven C, Brüning T; GENICA Network; Chang-Claude J, Wang-Gohrke S, Eilber U, Dörk T, Schürmann P, Bremer M, Hillemanns P, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova N, Antonenkova N, Rogov Y, Bermisheva M, Prokofyeva D, Zinnatullina G, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kosma VM, Hartikainen JM, Kataja V, Chenevix-Trench G, Beesley J, Chen X; kConFab Investigators; Australian Ovarian Cancer Study Group; Lambrechts D, Smeets A, Paridaens R, Weltens C, Flesch-Janys D, Buck K, Behrens S, Peterlongo P, Bernard L, Mano… See abstract for full author list ➔ Warren H, et al. Among authors: kosma vm. Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1783-91. doi: 10.1158/1055-9965.EPI-12-0526. Epub 2012 Aug 2. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22859399 Free PMC article.

2

Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.

Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: kosma vm. Pharmacogenetics. 2002 Jan;12(1):67-72. doi: 10.1097/00008571-200201000-00009. Pharmacogenetics. 2002. PMID: 11773866

3

Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.

Pellikainen J, Kataja V, Ropponen K, Kellokoski J, Pietiläinen T, Böhm J, Eskelinen M, Kosma VM. Pellikainen J, et al. Among authors: kosma vm. Clin Cancer Res. 2002 Nov;8(11):3487-95. Clin Cancer Res. 2002. PMID: 12429639

4

Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: kosma vm. Pharmacogenetics. 2004 Apr;14(4):239-45. doi: 10.1097/00008571-200404000-00003. Pharmacogenetics. 2004. PMID: 15083068

5

Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.

Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Pellikainen JM, et al. Among authors: kosma vm. Clin Cancer Res. 2004 Nov 15;10(22):7621-8. doi: 10.1158/1078-0432.CCR-04-1061. Clin Cancer Res. 2004. PMID: 15569994

6

NAT2 slow acetylator genotype as an important modifier of breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: kosma vm. Int J Cancer. 2005 Apr 20;114(4):579-84. doi: 10.1002/ijc.20677. Int J Cancer. 2005. PMID: 15609332

7

An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found.

Hartikainen JM, Tuhkanen H, Kataja V, Dunning AM, Antoniou A, Smith P, Arffman A, Pirskanen M, Easton DF, Eskelinen M, Uusitupa M, Kosma VM, Mannermaa A. Hartikainen JM, et al. Among authors: kosma vm. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):75-80. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668479

8

Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.

Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A. Sillanpää P, et al. Among authors: kosma vm. Pharmacogenet Genomics. 2005 Oct;15(10):749-52. doi: 10.1097/01.fpc.0000172240.34923.46. Pharmacogenet Genomics. 2005. PMID: 16141802

9

XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.

Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M, Hirvonen A. Metsola K, et al. Among authors: kosma vm. Breast Cancer Res. 2005;7(6):R987-97. doi: 10.1186/bcr1333. Epub 2005 Oct 11. Breast Cancer Res. 2005. PMID: 16280050 Free PMC article.

10

Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.

Hartikainen JM, Tuhkanen H, Kataja V, Eskelinen M, Uusitupa M, Kosma VM, Mannermaa A. Hartikainen JM, et al. Among authors: kosma vm. Clin Cancer Res. 2006 Mar 1;12(5):1454-62. doi: 10.1158/1078-0432.CCR-05-1417. Clin Cancer Res. 2006. PMID: 16533768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters